Biopharmaceutical Company Announces Notice of Allowance For Patent Over UC Treatment
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108.
Disclaimer: The following article is based on a press release from Palisade Bio and is intended for informational purposes only. It should not be taken as financial advice or an endorsement of any company or product.
As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and researc…